Evidence map›Paper›PMID 31399506›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2019

Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites.

Renato J Scialis, Lauren M Aleksunes, Iván L Csanaky, Curtis D Klaassen, José E Manautou

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Renato J ScialisDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut (R.J.S., J.E.M.), Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (L.M.A., I.L.C., C.D.K.) and Department of Internal Medicine, University of Kansas Medical Center, Kansas City (C.D.K.).
Lauren M AleksunesDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut (R.J.S., J.E.M.), Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (L.M.A., I.L.C., C.D.K.) and Department of Internal Medicine, University of Kansas Medical Center, Kansas City (C.D.K.).
Iván L CsanakyDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut (R.J.S., J.E.M.), Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (L.M.A., I.L.C., C.D.K.) and Department of Internal Medicine, University of Kansas Medical Center, Kansas City (C.D.K.).
Curtis D KlaassenDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut (R.J.S., J.E.M.), Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (L.M.A., I.L.C., C.D.K.) and Department of Internal Medicine, University of Kansas Medical Center, Kansas City (C.D.K.).
José E ManautouDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut (R.J.S., J.E.M.), Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (L.M.A., I.L.C., C.D.K.) and Department of Internal Medicine, University of Kansas Medical Center, Kansas City (C.D.K.) jose.manautou@uconn.edu.
University of Connecticut · USUniversity of Kansas Medical Center · US

Funding

Regulation of Hepatic Uptake of Endogenous Signaling Molecules and XenobioticsR01ES009649 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CSANAKY, IVAN · 2000 to 2014
$4.0M
Regulation of Hepatic Excretion of Xenobiotics by MrpsR01ES009716 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2000 to 2010
$3.2M
Transporter Expression in Response to HepatotoxicantsR01DK069557 · NIDDK · UNIVERSITY OF CONNECTICUT STORRS · PI MANAUTOU, JOSE E · 2005 to 2013
$2.4M
Coordinate Regulation of Uptake and Efflux TransportersR01ES013714 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2006 to 2010
$1.7M
NIDDK NIH HHS R01 DK069557NIEHS NIH HHS R01 ES009649NIEHS NIH HHS R01 ES009716NIEHS NIH HHS R01 ES013714
6 · The paper itself

Abstract

In the present work, in vivo transporter knockout (KO) mouse models were used to characterize the disposition of diclofenac (DCF) and its primary metabolites following a single subtoxic dose in mice lacking breast cancer resistance protein (Bcrp) or multidrug resistance-associated protein (Mrp)3. The results indicate that Bcrp acts as a canalicular efflux mediator for DCF, as wild-type (WT) mice had biliary excretion values that were 2.2- to 2.6-fold greater than Bcrp KO mice, although DCF plasma levels were not affected. The loss of Bcrp resulted in a 1.8- to 3.2-fold increase of diclofenac acyl glucuronide (DCF-AG) plasma concentrations in KO animals compared with WT mice, while the biliary excretion of DCF-AG increased 1.4-fold in WT versus KO mice. Furthermore, Mrp3 was found to mediate the basolateral transport of DCF-AG, but not DCF or 4'-hydroxy diclofenac. WT mice had DCF-AG plasma concentrations 7.0- to 8.6-fold higher than Mrp3 KO animals; however, there were no changes in biliary excretion of DCF-AG. Vesicular transport experiments with human MRP3 demonstrated that MRP3 is able to transport DCF-AG via low- and high-affinity binding sites. The low-affinity MRP3 transport had a

Indexed as

AnimalsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily G, Member 2DiclofenacGlucuronidesMaleMiceMice, KnockoutTissue Distribution1-O-(2-((2',6'-dichlorophenyl)amino)phenylacetyl)glucopyranuronic acidAbcg2 protein, mouseATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily G, Member 2DiclofenacGlucuronidesmultidrug resistance protein 3

Identifiers

PMID31399506
PMCPMC6750190
OpenAlexW2968018366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.